Search Results - "Dana, B. W."

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy by Dana, B W, Dahlberg, S, Nathwani, B N, Chase, E, Coltman, C, Miller, T P, Fisher, R I

“…We reviewed survival data of patients with low-grade lymphoma entered on Southwest Oncology Group (SWOG) lymphoma trials in 1972 to 1983 to determine the…”
Get more information

Trimethoprim-Sulfamethoxazole Prophylaxis in Granulocytopenic Patients with Acute Leukemia: Evaluation of Serum Antibiotic Levels in a Randomized, Double-Blind, Placebo-Controlled Department of Veterans Affairs Cooperative Study by Ward, T. T., Thomas, R. G., Fye, C. L., Arbeit, R., Coltman, C. A., Craig, W., Dana, B. W., Finegold, S. M., Lentino, J., Penn, R. L., Weinberg, J. B., Chow, B., Ochi, S.

“…Despite widespread use of trimethoprim-sulfamethoxazole (TMP-SMZ) for prophylaxis in neutropenic patients, questions remain regarding its efficacy, toxicity,…”
Get full text

Treating malignancies with curative intent: understanding growth and differentiation by Dana, B W

“…Cancer is due to changes in the genes that normally regulate cellular growth and differentiation. These genetic changes cause cells to grow without normal…”
Get more information

Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study by Miller, T P, Dahlberg, S, Salmon, S E, Williamson, S K, Belt, R J, Dana, B W, Fisher, R I

“…A phase II trial of esorubicin (4' deoxydoxorubicin) was conducted by the Southwest Oncology Group in 88 assessable patients with non-Hodgkin's lymphoma (NHL)…”
Get more information

Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors by FITCHEN, J. H, RISCOE, M. K, DANA, B. W, LAWRENCE, H. J, FERRO, A. J

“…5'-Methylthioadenosine (MTA) is a naturally occurring nucleoside which is degraded by MTA phosphorylase (MTAase) to adenine and methylthioribose-1-phosphate in…”
Get full text

A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis by Dana, B W, McDermott, M, Everts, E, Abdulhay, G

“…We compared the antiemetic efficacy of metoclopramide in a bolus low-dose infusion schedule to that of metoclopramide given in a conventional high-dose bolus…”
Get more information

Dexamethasone vs. placebo for cisplatin-induced emesis. A randomized cross-over trial by Dana, B W, Everts, E C, Dickinson, D

“…A randomized cross-over trial of dexamethasone (10 mg I.V. before therapy, and 4 mg I.V. q 4 h X 6 doses) vs. placebo as antiemetic therapy was conducted in 19…”
Get more information

Concomitant Administration of Granulocyte Transfusions and Amphotericin B in Neutropenic Patients: Absence of Significant Pulmonary Toxicity by Dana, Bruce W., Durie, Brian G.M., White, Ruby F., Huestis, Douglas W.

“…One hundred and ninety-five series of granulocyte transfusions in 144 patients were evaluated with respect to possible severe pulmonary toxicity from…”
Get full text

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial by Dana, B W, Dahlberg, S, Miller, T P, Hartsock, R J, Balcerzak, S, Coltman, C A, Carden, J O, Hartley, K, Fisher, R I

“…One hundred six eligible patients with advanced intermediate- or high-grade malignant lymphoma were treated with methotrexate with leucovorin rescue,…”
Get more information

Hairy cell leukemia by Dana, B W

Get more information

Adriamycin heart disease: an update by Dana, B W

Get more information

Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study by Dana, B W, Jones, S E, Coltman, C, Stuckey, W J

“…We tested the combination of cisplatin, amsacrine, and mitoguazone as salvage treatment for patients with advanced unfavorable non-Hodgkin's lymphomas. An…”
Get more information

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas by Miller, T P, Dana, B W, Weick, J K, Jones, S E, Coltman, C A, Dahlberg, S, Fisher, R I

“…The Southwest Oncology Group (SWOG) began testing doxorubicin-containing combination chemotherapy in 1972 using the cyclophosphamide, doxorubicin, vincristine,…”
Get more information

Primary penile lymphoma presenting as a penile ulcer by Fairfax, C A, Hammer, 3rd, C J, Dana, B W, Hanifin, J M, Barry, J M

“…Primary penile lymphoma is rare. The clinical manifestations can be quite subtle, which may lead to misdiagnosis. Treatments have included radical surgery,…”
Get more information

Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group study by Karanes, C, Crowley, J, Sawkar, L, Tranum, B L, Hicks, W J, Bonnet, J D, Dabich, L, Dana, B W, Salmon, S

“…Fifty-two patients with progressive resistant multiple myeloma were entered in this Southwest Oncology Group Phase II study, using weekly intravenous…”
Get full text

Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG by Dana, B W, Alberts, D S

“…Fourteen patients with advanced renal carcinoma were treated with Adriamycin 40 mg/m2 I.V., bleomycin 15 U/m2 I.V., vincristine 2 mg I.V., cyclophosphamide 200…”
Get more information

The significance of pulmonary infiltrates developing in patients receiving granulocyte transfusions by Dana, B W, Durie, B G, White, R F, Huestis, D W, Paplanus, S

Get more information

Interferon Alfa Consolidation After Intensive Chemotherapy Does Not Prolong the Progression-Free Survival of Patients With Low-Grade Non-Hodgkin’s Lymphoma: Results of the Southwest Oncology Group Randomized Phase III Study 8809 by Fisher, Richard I., Dana, Bruce W., LeBlanc, Michael, Kjeldsberg, Carl, Forman, Jeffrey D., Unger, Joseph M., Balcerzak, Stanley P., Gaynor, Ellen R., Roy, Vivek, Miller, Thomas

“…PURPOSE: S8809 is a randomized phase III trial determining whether intensive cytoreductive treatment, followed by interferon consolidation at the time of…”
Get full text

Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809 by Fisher, R I, Dana, B W, LeBlanc, M, Kjeldsberg, C, Forman, J D, Unger, J M, Balcerzak, S P, Gaynor, E R, Roy, V, Miller, T

“…S8809 is a randomized phase III trial determining whether intensive cytoreductive treatment, followed by interferon consolidation at the time of minimal…”
Get full text

Toxicity and Efficacy of Carboplatin and Etoposide in Conjunction with Disruption of the Blood-Brain Tumor Barrier in the Treatment of Intracranial Neoplasms by Williams, Paul C., Henner, W. David, Simon, Roman-Goldstein, Dahlborg, Suellen A., Brummett, Robert E., Tableman, Mara, Dana, Bruce W., Neuwelt, Edward A.

Get full text